Clinical Trials Logo

Allergic Conjunctivitis clinical trials

View clinical trials related to Allergic Conjunctivitis.

Filter by:

NCT ID: NCT01860664 Terminated - Clinical trials for Allergic Conjunctivitis

Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis

Start date: May 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety and effectiveness of hydrocortisone ophthalmic ointment compared to placebo in the treatment of Allergic Conjunctivitis.

NCT ID: NCT01808768 Unknown status - Clinical trials for Allergic Conjunctivitis

Ocular Allergy Treatment Practical Impact Trial

(OAT-PIT)
Start date: April 2013
Phase: Phase 4
Study type: Interventional

To study the impact of alcaftadine in patients treated with other opthalmic ocular agents (or specific topical opthalmic treatment) in an allergy subspecialist outpatient setting.

NCT ID: NCT01754766 Completed - Clinical trials for Allergic Conjunctivitis

AGN-229666 for the Treatment of Allergic Conjunctivitis

Start date: October 2012
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and efficacy of AGN-229666 for the treatment of allergic conjunctivitis.

NCT ID: NCT01743027 Completed - Clinical trials for Allergic Conjunctivitis

Efficacy and Safety of an Ophthalmic Solution in Patients With Allergic Conjunctivitis

Start date: January 2013
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate an ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis using the Conjunctival Allergen Challenge (CAC) model.

NCT ID: NCT01731249 Completed - Allergic Rhinitis Clinical Trials

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Start date: November 2010
Phase: Phase 3
Study type: Interventional

The purpose of this 2-year study is to assess the sustained clinical efficacy and safety of 300 IR/day of a sublingual solution of birch pollen allergen extract starting 4 months prior to the birch pollen season and continuing over the birch pollen season compared with placebo for reduction of rhinoconjunctivitis-related symptoms and anti-allergy medication usage.

NCT ID: NCT01698814 Completed - Clinical trials for Allergic Conjunctivitis

A Six-Week Safety Study of an Investigational Ophthalmic Solution

Start date: October 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic solution in subjects 2 years of age and older with asymptomatic eyes when administered once daily in both eyes for up to 6 weeks.

NCT ID: NCT01697969 Completed - Clinical trials for Allergic Conjunctivitis

Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

Start date: September 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to descriptively evaluate the corneal structures of allergic conjunctivitis patients.

NCT ID: NCT01686048 Completed - Asthma Clinical Trials

The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel

Start date: April 2015
Phase: N/A
Study type: Observational

Ambrosia is known for its allergenicity in the USA causing hay fever and asthma. Israel has always been considered "clean" of Ambrosia but over the past years growth of Ambrosia plants has been detected in several locations in Israel. In the proposed study, patients referred for routine allergic evaluation will also be skin tested with Ambrosia allergens, in addition to their regular prick skin tests with all other airborne allergens.

NCT ID: NCT01685242 Completed - Clinical trials for Allergic Conjunctivitis

A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle

Start date: September 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the onset and duration of action of AC-170 0.24% compared to vehicle in the prevention of the signs and symptoms of allergic conjunctivitis in the conjunctival allergen challenge (CAC) model.

NCT ID: NCT01679015 Completed - Clinical trials for Allergic Conjunctivitis

Evaluating Patients With Eye Allergies and Determining if There Are Also Dry Eyes

Start date: August 2012
Phase: N/A
Study type: Observational

Evaluating the percentage of patients that suffer from eye allergies and determining whether they also have dry eyes.